hydroxychloroquine decreases airflow and lowers circulating ige levels in subjects with moderate symptomatic asthma
hydroxychloroquine decreases airflow and lowers circulating ige levels in subjects with moderate symptomatic asthma
hydroxychloroquine (hcq) is a well-tolerated, safe immunomodulating drug, with proven efficacy in rheumatic diseases and known actions that suggest potential utility in the treatment of asthma.